drug · small molecule
bezuclastinib
pre_registrationupdated 3mo agoby $COGT Cogent Biosciences, Inc.🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying bezuclastinib
- —Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
- phase2(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- —Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
- phase2(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
- phase2SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that